What makes a compliant Phase III and pre-launch patient advocacy strategy?
{{output}}
Background: A key task for the pharmaceutical industry is to understand the compliance implications of engaging with a patient advocacy group (PAG). This presents challenges for the industry to negotiate the ethical and reputatio... ...
